Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT00181168
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
63
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Cancer
Interventions
DRUG:
Euthyroid Group
Sponsor
Johns Hopkins University
Collaborators
[object Object]
[object Object]
[object Object]